| Cas No.: | 1616871-34-1 |
| Chemical Name: | Sodium [(3S)-6-({4'-[(3S)-3,4-dihydroxybutoxy]-2,2',6'-trimethyl[1,1'-biphenyl]-3-yl}methoxy)-3H-spiro[1-benzofuran-2,1'-cyclopropan]-3-yl]acetate |
| Synonyms: | AS 2575959;AS-2575959 |
| Formula: | C32H35NaO7 |
| M.Wt: | 554.615 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | A novel potent, specific, orally available GPR40 agonist that influences glucose-dependent insulin secretion both in vitro pancreas β-cell-derived cells and in vivo; demonstrates a synergistic effect on insulin secretion and plasma GLP-1 level combined with DPP-IV inhibitor. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
